New York State Common Retirement Fund’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $68K | Hold |
21,868
| – | – | ﹤0.01% | 2852 |
|
|
2025
Q1 | $76K | Hold |
21,868
| – | – | ﹤0.01% | 2634 |
|
|
2024
Q4 | $72K | Hold |
21,868
| – | – | ﹤0.01% | 2727 |
|
|
2024
Q3 | $84K | Sell |
21,868
-23,100
| -51% | -$88.7K | ﹤0.01% | 2669 |
|
|
2024
Q2 | $139K | Buy |
44,968
+620
| +1% | +$1.92K | ﹤0.01% | 2587 |
|
|
2024
Q1 | $114K | Sell |
44,348
-658
| -1% | -$1.69K | ﹤0.01% | 2685 |
|
|
2023
Q4 | $113K | Sell |
45,006
-240
| -0.5% | -$603 | ﹤0.01% | 2702 |
|
|
2023
Q3 | $92K | Buy |
45,246
+473
| +1% | +$962 | ﹤0.01% | 2766 |
|
|
2023
Q2 | $103K | Sell |
44,773
-120
| -0.3% | -$276 | ﹤0.01% | 2798 |
|
|
2023
Q1 | $136K | Sell |
44,893
-30,513
| -40% | -$92.4K | ﹤0.01% | 2730 |
|
|
2022
Q4 | $176K | Sell |
75,406
-70
| -0.1% | -$163 | ﹤0.01% | 2780 |
|
|
2022
Q3 | $144K | Buy |
75,476
+344
| +0.5% | +$656 | ﹤0.01% | 2892 |
|
|
2022
Q2 | $204K | Buy |
75,132
+41,915
| +126% | +$114K | ﹤0.01% | 2795 |
|
|
2022
Q1 | $99K | Buy |
33,217
+41
| +0.1% | +$122 | ﹤0.01% | 3018 |
|
|
2021
Q4 | $129K | Sell |
33,176
-146
| -0.4% | -$568 | ﹤0.01% | 3012 |
|
|
2021
Q3 | $143K | Sell |
33,322
-33,578
| -50% | -$144K | ﹤0.01% | 3024 |
|
|
2021
Q2 | $203K | Buy |
+66,900
| New | +$203K | ﹤0.01% | 3035 |
|
|
2019
Q2 | – | Sell |
-24,500
| Closed | -$88K | – | 3236 |
|
|
2019
Q1 | $88K | Hold |
24,500
| – | – | ﹤0.01% | 2986 |
|
|
2018
Q4 | $94K | Hold |
24,500
| – | – | ﹤0.01% | 2977 |
|
|
2018
Q3 | $232K | Hold |
24,500
| – | – | ﹤0.01% | 2766 |
|
|
2018
Q2 | $179K | Buy |
+24,500
| New | +$179K | ﹤0.01% | 2917 |
|
|
2014
Q2 | – | Sell |
-135,650
| Closed | -$2.92M | – | 2000 |
|
|
2014
Q1 | $2.92M | Buy |
+135,650
| New | +$2.92M | ﹤0.01% | 1471 |
|